Cantor Ftizgerald Recent News
Cantor Still Recommending A Buy For T2 BioSystems
Cantor Fitzgerald Sees 81% Upside In Spark Therapeutics; Initiating with A Buy
Is Yahoo Getting Close To The Finish Line?
Cantor: Relypsa Sale Makes Sense
BDC Investors Take Note: This Midcap's Credit Quality Is Deteriorating
'Planet Apple' Makes Apple Worth $195/Share
The Latest 'Apple Barometer' Is In
SunTrust's Top 10 Questions For Twitter
Cantor Fitzgerald: Instagram More Popular Than Ever Among Marketers